Vimarsana
Biggest News Aggregation in the World

Page 6 - Nasdaq Pcvx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Pcvx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pcvx Today - Breaking & Trending Today

Vaxcyte (NASDAQ:PCVX) Announces Earnings Results - Vimarsana News

Vaxcyte (NASDAQ:PCVX) Announces Earnings Results

Vaxcyte (NASDAQ:PCVX – Get Free Report) issued its earnings results on Monday. The company reported ($0.91) earnings per share for the quarter, missing the consensus estimate of ($0.84) by ($0.07), Briefing.com reports. Vaxcyte Stock Up 0.7 % Shares of Vaxcyte stock opened at $50.60 on Thursday. Vaxcyte has a 12-month low of $34.11 and a […]

Moody Aldrich Partners LLC Makes New $1.23 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX) - Vimarsana News

Moody Aldrich Partners LLC Makes New $1.23 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX)

Moody Aldrich Partners LLC purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the second quarter, Holdings Channel.com reports. The fund purchased 24,665 shares of the company’s stock, valued at approximately $1,232,000. Other hedge funds and other institutional investors also recently made changes to their positions in the company. ETF […]

Source: wkrb13.com
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $65.00 - Vimarsana News

Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $65.00

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus rating of “Buy” by the six research firms that are presently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have issued ratings on the stock in the […]

Source: wkrb13.com
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells 15,000 Shares of Stock - Vimarsana News

Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells 15,000 Shares of Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $52.45, for a total value of $786,750.00. Following the sale, the chief executive officer now directly owns 400,914 shares in the […]

Reviewing Adaptimmune Therapeutics (NASDAQ:ADAP) and Vaxcyte (NASDAQ:PCVX) - Vimarsana News

Reviewing Adaptimmune Therapeutics (NASDAQ:ADAP) and Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Get Free Report) and Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings […]